Aspen Pharmacare Holdings Ltd

Here is the public summary page for Aspen Pharmacare Holdings Ltd. Please login to see the complete information for Aspen Pharmacare Holdings Ltd including detailed analysis of price, sentiment, fundamentals, flow, forecast models, alerts and much more. Also you can see how Aspen Pharmacare Holdings Ltd stacks up relative to its peers.


Darwin Score+1
TickerAPN
Latest Price11730.00 ZAR as of close on 31-Jul-2025
3 Month price range11200.00 to 16366.00 ZAR
Market Capitalisation52.79Bn ZAR
CountrySouth Africa
Economic SectorHealth Care
Business SectorPharmaceuticals, Biotechnology & Life Sciences
IndustryPharmaceuticals
Sub-IndustryPharmaceuticals
Description
Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general, local, and regional anesthetic; low molecular weight heparin; regional and spinal anesthetic; and opioid analegesic under the Diprivan, Emla, Fraxiparine, Marcaine, Ultiva, and Xylocaine brand names. It also offers such as sleeping aid, thyroid hormone, immunosuppressant, iron supplement, analgesic anti-inflammatory, and hormone replacement therapy under the Circadin, Eltroxin, Foxair, Imuran, Maltofer, Mybulen, and Ovestin brand names. In addition, the company manufactures and sells active pharmaceutical ingredients and finished dose form products. Aspen Pharmacare Holdings Limited was founded in 1850 and is headquartered in Durban, South Africa.
See More ...
Company URLhttps://www.aspenpharma.com
See Darwins Full Analysis for Aspen Pharmacare Holdings Ltd

Tell Me About

Tell Me About (TMA) is Darwins structured scoring system for assets. Here are the scores from the key TMA sections for Aspen Pharmacare Holdings Ltd. Further information and full detail is available when you login.

TMA PartFocus of AnalysisTMA Score
PriceAnalysis of performance, trend, RSI, OBV and moving averages-5
SentimentNews and Candle Patterns. 0
FundamentalsAnalyst Ratings, Valuation and Dividend analysis.0
FlowInstitutional, Fund and Insider buying and selling.0
ModelsForecast models.+6

Share Share on Facebook Share on Twitter Share on Threads Share on LinkedIn